LGT Capital Partners’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-315,000
Closed -$3.15M 51
2024
Q2
$3.15M Sell
315,000
-635,000
-67% -$6.45M 0.11% 50
2024
Q1
$10.9M Sell
950,000
-50,000
-5% -$425K 0.34% 43
2023
Q4
$7.29M Buy
1,000,000
+442,500
+79% +$3.49M 0.22% 45
2023
Q3
$5.07M Hold
557,500
0.18% 56
2023
Q2
$6.78M Hold
557,500
0.23% 53
2023
Q1
$6.93M Buy
557,500
+127,500
+30% +$2.35M 0.19% 50
2022
Q4
$8.26M Buy
430,000
+230,000
+115% +$4.86M 0.24% 42
2022
Q3
$3.76M Buy
+200,000
New +$4.11M 0.11% 55

Other funds holding AHCO

LGT Capital Partners's AHCO Position: Q3 2024 in Review

LGT Capital Partners sold out of AdaptHealth (AHCO) in Q3 2024, closing a stake of 315,000 shares — an estimated $3.15M sold.

LGT Capital Partners first reported a position in AHCO in Q3 2022 and held it in 8 quarters. The position peaked at $10.9M in Q1 2024. 217 funds tracked by Wall St. Rank hold AHCO as of Q3 2024.

  • LGT Capital Partners reported no remaining AdaptHealth position as of Q3 2024 after selling out during the quarter.
  • LGT Capital Partners sold 315,000 AdaptHealth shares in Q3 2024, an estimated $3.15M.
  • LGT Capital Partners first reported a position in AdaptHealth in Q3 2022 and held it in 8 quarters.
  • LGT Capital Partners's AdaptHealth position peaked at $10.9M in Q1 2024.
  • 217 funds tracked by Wall St. Rank held AdaptHealth as of Q3 2024.

Based on LGT Capital Partners's 13F filing for Q3 2024, filed 8 Nov 2024.